Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 18, 2019
Patients' experience and compliance with extended low molecular weight heparin prophylaxis post-surgery for gynecological cancer: a prospective observational studyZibi Marchocki, Lucy Norris, Sharon O'Toole, et al.
Irish Journal of Medical Science|August 4, 2018
Lung metastases from benign uterine leiomyoma: does 18-FDG-PET/CT have a role to play?Feras Abu Saadeh, Ciaran O Riain, Ciara Mc Cormack, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 27, 2019
Incidence, management, and sequelae of ureteric obstruction in women with cervical cancerPatrick J Maguire, Aleksandra Sobota, Doug Mulholland, et al.
Obstetric Medicine|August 12, 2016
Two case reports of generalized pustular psoriasis of pregnancy: Different outcomesAoibheann Flynn, Naomi Burke, Bridgette Byrne, et al.
Gynecologic Oncology Reports|January 3, 2022
Severe lymphoedema in gynaecological cancers: Impact of pneumatic compression on quality of lifeAoife Freyne, Niamh O Donoghue, Yulia Shahabuddin, et al.
Medicina (Kaunas, Lithuania)|December 24, 2021
Accuracy of Opportunistic Bone Mineral Density Assessment on Staging Computed Tomography for Gynaecological CancersCatherine Anne O'Gorman, Sarah Milne, Gerard Lambe, et al.
Irish Journal of Medical Science|January 5, 2018
Risk reduction surgery (RRS) for tubo-ovarian cancer in an Irish gynaecological practice: an analysis of indications and outcomesClaire Thompson, Ciara McCormick, Waseem Kamran, et al.
Thrombosis Research|October 8, 2013
Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis riskFeras Abu Saadeh, Lucy Norris, Sharon O'Toole, et al.
Thrombosis Research|February 11, 2021
Procoagulant activity in high grade serous ovarian cancer patients following neoadjuvant chemotherapy-The role of the activated protein C pathwayMark P Ward, Feras Abu Saadeh, Sharon A O'Toole, et al.
Human Pathology|October 29, 2017
miR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinomaFlorence A Arts, Lisa Keogh, Paul Smyth, et al.
Pageof 4